Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001012975-18-001273
Filing Date
2018-12-04
Accepted
2018-12-04 16:08:50
Documents
1
Period of Report
2018-11-30

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 8902
  Complete submission text file 0001012975-18-001273.txt   10461
Mailing Address 910 CLOPPER ROAD SUITE 201S GAITHERSBURG MD 20878
Business Address 910 CLOPPER ROAD SUITE 201S GAITHERSBURG MD 20878 2406541450
Altimmune, Inc. (Issuer) CIK: 0001326190 (see all company filings)

EIN.: 202726770 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 4819 EMPEROR BOULEVARD SUITE 400 DURHAM NC 27703
Business Address
Garg Vipin K (Reporting) CIK: 0001515813 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-32587 | Film No.: 181216916